AngioDynamics, Inc. (ANGO)
15.78
+0.03
(+0.19%)
USD |
NASDAQ |
Aug 24, 16:00
15.78
0.00 (0.00%)
After-Hours: 20:00
AngioDynamics Shareholders Equity (Quarterly) : 170.82M for May 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| May 31, 2026 | 170.82M |
| February 28, 2026 | 173.36M |
| November 30, 2025 | 176.33M |
| August 31, 2025 | 178.86M |
| May 31, 2025 | 182.97M |
| February 28, 2025 | 185.87M |
| November 30, 2024 | 186.77M |
| August 31, 2024 | 196.58M |
| May 31, 2024 | 205.59M |
| February 29, 2024 | 218.70M |
| November 30, 2023 | 401.23M |
| August 31, 2023 | 427.80M |
| May 31, 2023 | 378.30M |
| February 28, 2023 | 397.66M |
| November 30, 2022 | 407.96M |
| August 31, 2022 | 414.04M |
| May 31, 2022 | 424.49M |
| February 28, 2022 | 429.69M |
| November 30, 2021 | 432.37M |
| August 31, 2021 | 435.95M |
| May 31, 2021 | 439.46M |
| February 28, 2021 | 454.94M |
| November 30, 2020 | 454.34M |
| August 31, 2020 | 455.05M |
| May 31, 2020 | 454.87M |
| Date | Value |
|---|---|
| February 29, 2020 | 610.48M |
| November 30, 2019 | 613.81M |
| August 31, 2019 | 614.07M |
| May 31, 2019 | 614.82M |
| February 28, 2019 | 554.08M |
| November 30, 2018 | 549.56M |
| August 31, 2018 | 544.89M |
| May 31, 2018 | 542.60M |
| February 28, 2018 | 538.33M |
| November 30, 2017 | 521.22M |
| August 31, 2017 | 517.88M |
| May 31, 2017 | 515.03M |
| February 28, 2017 | 531.75M |
| November 30, 2016 | 523.35M |
| August 31, 2016 | 512.72M |
| May 31, 2016 | 507.23M |
| February 29, 2016 | 550.74M |
| November 30, 2015 | 547.64M |
| August 31, 2015 | 547.12M |
| May 31, 2015 | 545.02M |
| February 28, 2015 | 543.76M |
| November 30, 2014 | 543.57M |
| August 31, 2014 | 539.68M |
| May 31, 2014 | 536.84M |
| February 28, 2014 | 537.69M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Boston Scientific Corp. | 24.93B |
| Penumbra, Inc. | 1.531B |
| Abbott Laboratories | 51.11B |
| Alphatec Holdings, Inc. | 11.53M |
| AtriCure, Inc. | 516.43M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 267.16M |
| Total Liabilities (Quarterly) | 96.34M |
| Debt to Equity Ratio | 0.0641 |
| Current Ratio | 2.183 |
| Net Debt Paydown Yield | -0.27% |